PERIODONTOSIS CHARACTERIZATION OF THE NEUTROPHIL DEFECT
Project Number5R01DE006436-08
Contact PI/Project LeaderVAN DYKE, THOMAS E
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
The long range goal of this investigation has been the furthering
of our knowledge of the structural and functional relationships of
the inflammatory process, by defining the complex interactions
between the neutrophil and its environment. To date, this has
been accomplished by the study of neutrophils from Localized
Juvenile Periodontitis (LJP) patients which exhibit defects in
measureable functions. During the previous six years of this
grant, work has focused upon the neutrophil surface. The aims of
the previous proposals sought to elucidate the biochemical defects
of the LJP neutrophil and how these variations translated into
functional abnormalitites. As a logical extension of these studies,
the currently proposed work will focus upon the next step in the
process of cellular recognition, that of signal transduction.
Again, the defective LJP neutrophil will serve as a disease model
for investigation.
To further elucidate the transduction of membrane signals in the
human neutrophil, employing the LJP defect model as a probe of
these pathways, the following experiments are proposed:
1. To determine the effects of the phosphodiesterase inhibitor
isobutylmethylxanthine (IBMX) on the chemotactic function of
human polymorphonuclear leukocytes from LJP patients and
normal controls. Based upon the putative roles of cAMP and
cGMP as second messengers in receptor-ligand interaction, the
cAMP and cGMP levels of LJP and controls will be determined
before and after stimulation with FMLP and C5a.
2. Since the receptor density for FMLP and C5a is known to be
reduced in resting LJP neutrophils, the next aim is to evaluate
receptor number and density on neutrophils defective in
chemotaxis before and after IBMX treatment.
3. In order to better understand the stages of signal transduction
and to understand the role of phospholipase C and protein kinase
C in LJP neutrophils, intracellular Calcium ion translocation will
be monitored using fluorescent probes. Release of membrane
bound Ca++ will be monitored by fluorescent changes of cells
labelled with chlortetracycline and release of Ca++ into the
cytotsol will be measured by fluorescent changes in cells
prelabelled with Quin-2 or Fura-2.
4. Protein kinase C has been implicated in the activation
sequence for normal human neutrophils. Based upon preliminary
data implicating a protein kinase C abnormality in LJP,
experiments will be performed to determine if the activation of
protein kinase C is a requirement for initiation of chemotaxis in
LJP neutrophils or if the protein kinase C response is altered in
LJP. To begin, these determinations will be made by
measurements of protein kinase C activity and translocation.
National Institute of Dental and Craniofacial Research
CFDA Code
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
01-July-1982
Project End Date
30-June-1991
Budget Start Date
01-July-1989
Budget End Date
30-June-1990
Project Funding Information for 1989
Total Funding
$150,521
Direct Costs
$99,027
Indirect Costs
$51,494
Year
Funding IC
FY Total Cost by IC
1989
National Institute of Dental and Craniofacial Research
$150,521
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DE006436-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DE006436-08
Patents
No Patents information available for 5R01DE006436-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DE006436-08
Clinical Studies
No Clinical Studies information available for 5R01DE006436-08
News and More
Related News Releases
No news release information available for 5R01DE006436-08
History
No Historical information available for 5R01DE006436-08
Similar Projects
No Similar Projects information available for 5R01DE006436-08